Visakhapatnam (Andhra Pradesh) [India], July 15 (ANI): A five-member committee appointed by District Collector Vinay Chand, to probe into Monday night's fire incident at a pharmaceutical company in the JN Pharma City at Parawada here, submitted its preliminary report on Tuesday evening.
Visakhapatnam (Andhra Pradesh) [India], July 14 (ANI): At least one person was injured in a fire that broke out at a pharmaceutical company in JN Pharma City at Parawada in Visakhapatnam late on Monday night, police said.
Visakhapatnam (Andhra Pradesh) [India], July 14 (ANI): A massive fire broke out at a pharmaceutical company in JN Pharma City at Parawada in Visakhapatnam late on Monday night.
Chandigarh [India], July 13 (ANI): Punjab Finance Minister Manpreet Singh Badal on Monday met Union Minister of Chemicals and Fertilisers DV Sadananda Gowda and sought the establishment of a national pharmaceutical park in Bathinda.
Mumbai (Maharashtra) [India], July 13 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced that it has commenced a Post Marketing Surveillance (PMS) study on FabiFlu® to closely monitor the efficacy and safety of the drug in
Mumbai (Maharashtra) [India], July 13 (ANI): Glenmark Pharmaceuticals said on Monday it has cut the price of its anti-viral drug Favipiravir under the brand name FabiFlu for treatment of patients with mild to moderate COVID-19 by 27 per cent to Rs 75 per tablet.
New Delhi [India], July 9 (ANI): In a virtual global address, Prime Minister Narendra Modi on Thursday said Indian pharmaceutical industry has been an "asset" not just for its own country but also for the entire world as it leads to "reducing the cost of medicine" for developing countries
Mumbai (Maharashtra) [India], July 7 (ANI): Indian pharmaceutical companies have built a strong abbreviated new drug application (ANDA) pipeline since FY12 through scaling-up of investments in R&D but this will increase the inspection intensity, India Ratings and Research (Ind-Ra) said o
Bengaluru (Karnataka) [India], July 7 (ANI): Global pharmaceutical major Mylan has got approval for its remdesivir from the Drug Controller General of India (DCGI) and will launch a generic version of Gilead Sciences' COVID-19 anti-viral in the country at Rs 4,800 for 100 mg/vial.
Ahmedabad (Gujarat) [India], July 6 (ANI): Pharmaceutical major Zydus Cadila said on Monday it has got approval from Mexico's Federal Commission for the Protection against Sanitary Risk (COFEPRIS) for its one of its lead research candidate Desidustat to be tested in the management of COVID-1
New Delhi [India], July 2 (ANI): In the wake of COVID-19 pandemic, government is striving to ensure sufficient availability of critical medical equipment for clinical management of COVID-19 in the country, said Ministry of Chemicals and Fertilizers.